Odontoprev SA operates within the Offices and clinics of dentists sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Odontoprev SA with three other
health care providers in Latin America:
Medica Sur S.A.B. de c.v.
of MEXICO
(2020
sales of 4.47 billion Mexican Pesos [US$222.33 million]
of which 60%
was Diagnosis),
Instituto de Diagnostico SA
of CHILE
(139.36 billion Chilean Pesos [US$176.98 million]
of which 70%
was Hospitalization), and
Clinica Las Condes SA
which is
also
based in CHILE
(212.27 billion Chilean Pesos [US$269.58 million]
of which 67%
was Hospital).
Sales Analysis.
During the second
quarter of 2021, sales at Odontoprev SA totalled
454.60 million Brazilian Reals.
This is
an increase of 5.0%
from the 432.96 million Brazilian Reals in sales at the company during the second quarter of 2020.
During the first two
quarters of 2021, sales totalled 906.01 million Brazilian Reals, which is
2.0% higher
than through the first two quarters of 2020.
There appears to be at least some degree of seasonality in the sales at Odontoprev SA: during 8 of the previous 9
years, sales were highest during the fourth quarter.
The exception to this was during 2020, when the
first quarter was the best quarter, accounting for
26% of sales (during that same year, the
fourth quarter accounted for 25% of sales).
During the year ended December of 2020, sales at
Odontoprev SA were 1.77 billion Brazilian Reals (US$333.77 million).
This
is
a
decrease of 2.4%
versus 2019, when the company's sales were 1.81 billion Brazilian Reals.
Contributing to the drop in overall sales was the 8.2% decline
in Other, from 19.10 million Brazilian Reals to 17.53 million Brazilian Reals.
There were also decreases in sales in
Corporate/pre-Paid (down 1.4% to 1.01 billion Brazilian Reals)
and
Individual/pre-Paid (down 4.7% to 433.94 million Brazilian Reals)
.
However, these declines were partially offset by the increase in sales of
Corporate/post-Paid (up 2.6% to 304.78 million Brazilian Reals)
.